1 Ertapenem Injection Market Overview 1.1 Product Overview and Scope of Ertapenem Injection 1.2 Ertapenem Injection Segment by Type 1.2.1 Global Ertapenem Injection Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 1g/Vial 1.2.3 Others 1.3 Ertapenem Injection Segment by Application 1.3.1 Global Ertapenem Injection Sales Comparison by Application: (2021-2027) 1.3.2 Adult 1.3.3 Pediatric 1.4 Global Ertapenem Injection Market Size Estimates and Forecasts 1.4.1 Global Ertapenem Injection Revenue 2016-2027 1.4.2 Global Ertapenem Injection Sales 2016-2027 1.4.3 Ertapenem Injection Market Size by Region: 2016 Versus 2021 Versus 2027 2 Ertapenem Injection Market Competition by Manufacturers 2.1 Global Ertapenem Injection Sales Market Share by Manufacturers (2016-2021) 2.2 Global Ertapenem Injection Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Ertapenem Injection Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Ertapenem Injection Manufacturing Sites, Area Served, Product Type 2.5 Ertapenem Injection Market Competitive Situation and Trends 2.5.1 Ertapenem Injection Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Ertapenem Injection Players Market Share by Revenue 2.5.3 Global Ertapenem Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Ertapenem Injection Retrospective Market Scenario by Region 3.1 Global Ertapenem Injection Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Ertapenem Injection Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Ertapenem Injection Market Facts & Figures by Country 3.3.1 North America Ertapenem Injection Sales by Country 3.3.2 North America Ertapenem Injection Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Ertapenem Injection Market Facts & Figures by Country 3.4.1 Europe Ertapenem Injection Sales by Country 3.4.2 Europe Ertapenem Injection Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Ertapenem Injection Market Facts & Figures by Region 3.5.1 Asia Pacific Ertapenem Injection Sales by Region 3.5.2 Asia Pacific Ertapenem Injection Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Ertapenem Injection Market Facts & Figures by Country 3.6.1 Latin America Ertapenem Injection Sales by Country 3.6.2 Latin America Ertapenem Injection Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Ertapenem Injection Market Facts & Figures by Country 3.7.1 Middle East and Africa Ertapenem Injection Sales by Country 3.7.2 Middle East and Africa Ertapenem Injection Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Ertapenem Injection Historic Market Analysis by Type 4.1 Global Ertapenem Injection Sales Market Share by Type (2016-2021) 4.2 Global Ertapenem Injection Revenue Market Share by Type (2016-2021) 4.3 Global Ertapenem Injection Price by Type (2016-2021) 5 Global Ertapenem Injection Historic Market Analysis by Application 5.1 Global Ertapenem Injection Sales Market Share by Application (2016-2021) 5.2 Global Ertapenem Injection Revenue Market Share by Application (2016-2021) 5.3 Global Ertapenem Injection Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Merck 6.1.1 Merck Corporation Information 6.1.2 Merck Description and Business Overview 6.1.3 Merck Ertapenem Injection Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Merck Ertapenem Injection Product Portfolio 6.1.5 Merck Recent Developments/Updates 6.2 Endo 6.2.1 Endo Corporation Information 6.2.2 Endo Description and Business Overview 6.2.3 Endo Ertapenem Injection Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Endo Ertapenem Injection Product Portfolio 6.2.5 Endo Recent Developments/Updates 6.3 Aurobindo Pharma 6.3.1 Aurobindo Pharma Corporation Information 6.3.2 Aurobindo Pharma Description and Business Overview 6.3.3 Aurobindo Pharma Ertapenem Injection Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Aurobindo Pharma Ertapenem Injection Product Portfolio 6.3.5 Aurobindo Pharma Recent Developments/Updates 6.4 ACS Dobfar 6.4.1 ACS Dobfar Corporation Information 6.4.2 ACS Dobfar Description and Business Overview 6.4.3 ACS Dobfar Ertapenem Injection Sales, Revenue and Gross Margin (2016-2021) 6.4.4 ACS Dobfar Ertapenem Injection Product Portfolio 6.4.5 ACS Dobfar Recent Developments/Updates 7 Ertapenem Injection Manufacturing Cost Analysis 7.1 Ertapenem Injection Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Ertapenem Injection 7.4 Ertapenem Injection Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Ertapenem Injection Distributors List 8.3 Ertapenem Injection Customers 9 Ertapenem Injection Market Dynamics 9.1 Ertapenem Injection Industry Trends 9.2 Ertapenem Injection Growth Drivers 9.3 Ertapenem Injection Market Challenges 9.4 Ertapenem Injection Market Restraints 10 Global Market Forecast 10.1 Ertapenem Injection Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Ertapenem Injection by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Ertapenem Injection by Type (2022-2027) 10.2 Ertapenem Injection Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Ertapenem Injection by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Ertapenem Injection by Application (2022-2027) 10.3 Ertapenem Injection Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Ertapenem Injection by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Ertapenem Injection by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Ertapenem Injection Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Ertapenem Injection Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Ertapenem Injection Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Ertapenem Injection Covered in This Study Table 5. Global Ertapenem Injection Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Ertapenem Injection Sales Market Share by Manufacturers (2016-2021) Table 7. Global Ertapenem Injection Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Ertapenem Injection Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Ertapenem Injection Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Ertapenem Injection Manufacturing Sites and Area Served Table 11. Manufacturers Ertapenem Injection Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Ertapenem Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ertapenem Injection as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Ertapenem Injection Sales by Region (2016-2021) & (K Units) Table 16. Global Ertapenem Injection Sales Market Share by Region (2016-2021) Table 17. Global Ertapenem Injection Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Ertapenem Injection Sales by Country (2016-2021) & (K Units) Table 19. North America Ertapenem Injection Sales Market Share by Country (2016-2021) Table 20. North America Ertapenem Injection Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Ertapenem Injection Revenue Market Share by Country (2016-2021) Table 22. Europe Ertapenem Injection Sales by Country (2016-2021) & (K Units) Table 23. Europe Ertapenem Injection Sales Market Share by Country (2016-2021) Table 24. Europe Ertapenem Injection Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Ertapenem Injection Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Ertapenem Injection Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Ertapenem Injection Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Ertapenem Injection Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Ertapenem Injection Revenue Market Share by Region (2016-2021) Table 30. Latin America Ertapenem Injection Sales by Country (2016-2021) & (K Units) Table 31. Latin America Ertapenem Injection Sales Market Share by Country (2016-2021) Table 32. Latin America Ertapenem Injection Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Ertapenem Injection Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Ertapenem Injection Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Ertapenem Injection Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Ertapenem Injection Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Ertapenem Injection Revenue Market Share by Country (2016-2021) Table 38. Global Ertapenem Injection Sales (K Units) by Type (2016-2021) Table 39. Global Ertapenem Injection Sales Market Share by Type (2016-2021) Table 40. Global Ertapenem Injection Revenue (Million US$) by Type (2016-2021) Table 41. Global Ertapenem Injection Revenue Share by Type (2016-2021) Table 42. Global Ertapenem Injection Price (USD/Unit) by Type (2016-2021) Table 43. Global Ertapenem Injection Sales (K Units) by Application (2016-2021) Table 44. Global Ertapenem Injection Sales Market Share by Application (2016-2021) Table 45. Global Ertapenem Injection Revenue (Million US$) by Application (2016-2021) Table 46. Global Ertapenem Injection Revenue Share by Application (2016-2021) Table 47. Global Ertapenem Injection Price (USD/Unit) by Application (2016-2021) Table 48. Merck Corporation Information Table 49. Merck Description and Business Overview Table 50. Merck Ertapenem Injection Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Merck Ertapenem Injection Product Table 52. Merck Recent Developments/Updates Table 53. Endo Corporation Information Table 54. Endo Description and Business Overview Table 55. Endo Ertapenem Injection Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Endo Ertapenem Injection Product Table 57. Endo Recent Developments/Updates Table 58. Aurobindo Pharma Corporation Information Table 59. Aurobindo Pharma Description and Business Overview Table 60. Aurobindo Pharma Ertapenem Injection Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Aurobindo Pharma Ertapenem Injection Product Table 62. Aurobindo Pharma Recent Developments/Updates Table 63. ACS Dobfar Corporation Information Table 64. ACS Dobfar Description and Business Overview Table 65. ACS Dobfar Ertapenem Injection Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. ACS Dobfar Ertapenem Injection Product Table 67. ACS Dobfar Recent Developments/Updates Table 68. Production Base and Market Concentration Rate of Raw Material Table 69. Key Suppliers of Raw Materials Table 70. Ertapenem Injection Distributors List Table 71. Ertapenem Injection Customers List Table 72. Ertapenem Injection Market Trends Table 73. Ertapenem Injection Growth Drivers Table 74. Ertapenem Injection Market Challenges Table 75. Ertapenem Injection Market Restraints Table 76. Global Ertapenem Injection Sales Forecast by Type (2022-2027) & (K Units) Table 77. Global Ertapenem Injection Sales Market Share Forecast by Type (2022-2027) Table 78. Global Ertapenem Injection Revenue Forecast by Type (2022-2027) & (US$ Million) Table 79. Global Ertapenem Injection Revenue Market Share Forecast by Type (2022-2027) Table 80. Global Ertapenem Injection Sales Forecast by Application (2022-2027) & (K Units) Table 81. Global Ertapenem Injection Sales Market Share Forecast by Application (2022-2027) Table 82. Global Ertapenem Injection Revenue Forecast by Application (2022-2027) & (US$ Million) Table 83. Global Ertapenem Injection Revenue Market Share Forecast by Application (2022-2027) Table 84. Global Ertapenem Injection Sales Forecast by Region (2022-2027) & (K Units) Table 85. Global Ertapenem Injection Sales Market Share Forecast by Region (2022-2027) Table 86. Global Ertapenem Injection Revenue Forecast by Region (2022-2027) & (US$ Million) Table 87. Global Ertapenem Injection Revenue Market Share Forecast by Region (2022-2027) Table 88. Research Programs/Design for This Report Table 89. Key Data Information from Secondary Sources Table 90. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Ertapenem Injection Figure 2. Global Ertapenem Injection Market Share by Type in 2020 & 2027 Figure 3. 1g/Vial Product Picture Figure 4. Others Product Picture Figure 5. Global Ertapenem Injection Market Share by Application in 2020 & 2027 Figure 6. Adult Figure 7. Pediatric Figure 8. Global Ertapenem Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Ertapenem Injection Market Size 2016-2027 (US$ Million) Figure 10. Global Ertapenem Injection Sales 2016-2027 (K Units) Figure 11. Global Ertapenem Injection Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 12. Ertapenem Injection Sales Share by Manufacturers in 2020 Figure 13. Global Ertapenem Injection Revenue Share by Manufacturers in 2020 Figure 14. The Global 5 and 10 Largest Ertapenem Injection Players: Market Share by Revenue in 2020 Figure 15. Ertapenem Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 16. Global Ertapenem Injection Sales Market Share by Region (2016-2021) Figure 17. Global Ertapenem Injection Sales Market Share by Region in 2020 Figure 18. Global Ertapenem Injection Revenue Market Share by Region (2016-2021) Figure 19. Global Ertapenem Injection Revenue Market Share by Region in 2020 Figure 20. U.S. Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 21. Canada Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Germany Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. France Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. U.K. Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Italy Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Russia Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. China Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Japan Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. South Korea Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. India Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Australia Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Taiwan Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Indonesia Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Thailand Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Malaysia Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Philippines Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Vietnam Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Mexico Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Brazil Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Argentina Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Turkey Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Saudi Arabia Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. U.A.E Ertapenem Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Sales Market Share of Ertapenem Injection by Type (2016-2021) Figure 45. Sales Market Share of Ertapenem Injection by Application (2016-2021) Figure 46. Sales Market Share of Ertapenem Injection by Application in 2020 Figure 47. Revenue Share of Ertapenem Injection by Application (2016-2021) Figure 48. Revenue Share of Ertapenem Injection by Application in 2020 Figure 49. Manufacturing Cost Structure of Ertapenem Injection Figure 50. Manufacturing Process Analysis of Ertapenem Injection Figure 51. Ertapenem Injection Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Merck Endo Aurobindo Pharma ACS Dobfar